difficulty walking; Anxiety; dizziness/Woozy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non- HCP) from medical information team. The reporter is the patient.  A 27-year-old female patient received bnt162b2 (COMIRNATY), intramuscular, administered in arm left, administration date 20Aug2021 13:00 (Lot number: FD8448) at the age of 27 years as dose 1, 0.3 ml single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 20Aug2021, outcome "not recovered", described as "dizziness/Woozy"; GAIT DISTURBANCE (non-serious) with onset 29Aug2021, outcome "not recovered", described as "difficulty walking"; ANXIETY (non-serious) with onset 20Aug2021, outcome "recovered" (20Aug2021), described as "Anxiety". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of dizziness, gait disturbance, anxiety.  Additional information: This female consumer (patient) reported for herself that: patient experiencing dizziness and difficulty walking after the first dose of Comirnaty. Caller reports having dizziness that began that day and has since gotten worse. Caller states she is now having difficulty walking as a result. Caller states she was seen twice by her primary care doctor after this began, the second visit being today. Caller asking if dizziness is a commonly reported side effect of the Comirnaty Vaccine. Caller asking if she should get the second dose of Comirnaty and if it would be possible to get a medical exemption from the second dose. Caller asking if she should get the second dose of Comirnaty and if it would be possible to get a medical exemption from the second dose. We refer you to speak to your healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. Your healthcare provider knows your health situation and has access to information that can better help inform this decision." Advised caller that a medical exemption cannot come from Pfizer; she must request this from her HCP. NDC number of Pfizer covid vaccine: Unknown. Expiry Date of Pfizer covid vaccine: Unknown. She got her first dose on 20Aug2021 at her campus. She noticed within 5 to 10 minutes that she felt very woozy and got very dizzy. Her anxiety kicked in since she was unaware of her symptoms. They pulled her aside and calmed her down and the anxiety went away. It has been almost 3 weeks and her dizziness has not gone away and has been difficult for her to walk. Asking if this is a common side effect and if it gets better. Dizziness occurs from the time she wakes up till the time she sleeps, the whole day. Worsening little by little. Difficulty walking, she noticed on 29Aug2021 and last night she could not walk more than 15 minutes. Treatment: declines any. She is in the process of getting blood work to see if everything is fine. Second dose due 10Sep2021. She does not feel comfortable getting the second dose due to events mentioned with first dose. Asks how she can be exempt. Advised to talk to HCP. Vaccination Facility Type: (Privacy). History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available: none. Additional Vaccines Administered on Same Date of the Pfizer Suspect: none. Emergency Room? Yes because of the dizziness. Confirms she was not admitted. Prior Vaccinations (within 4 weeks):  none. AE(s) following prior vaccinations: None. Patient's Medical History: none. Family Medical History Relevant to AE(s): no. Relevant Tests: She is in the process of getting blood work to see if everything is fine.  No follow-up attempts are possible. No further information is expected.